National Centre for Cell Science

Trimetallic Cu–Zn–Fe Layered Double Hydroxide Nanocarrier Enabling On-Demand Anticancer Drug Release with Prolonged Therapeutic Windows for Precision Oncology

Clinical oncology faces a critical technological bottleneck driven by the rapid emergence of therapy-resistant tumors. Melanoma, in particular, remains a highly aggressive malignancy with pronounced metastatic potential and poor responsiveness to traditional therapy, signify the...